secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001964738-25-000013
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum Q4 2024: GAAP EPS $0.17, adj. EPS $1.41, organic sales +2.3%
----------------------------------------------------------------------

- GAAP diluted EPS $0.17; adjusted EPS $1.41; sales $2,074M (+1.9% reported, +2.3% organic).
- GAAP operating income $136M (6.6% margin); adjusted $422M (20.4% margin); MedSurg and Dental drove growth.
- Generated $219M cash from operations; free cash flow $92M.
- Full-year 2024: sales $8,254M, GAAP EPS $2.76, adjusted EPS $6.70, free cash flow $805M.
- Introduced FY 2025 guidance for organic sales growth, adjusted EPS, and free cash flow (specific figures not provided).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000013/0001964738-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000013/solv-20250227.htm
  HTML page:      https://secwatch.observer/filing/0001964738-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer